Horizon Kinetics Asset Management LLC Abb Vie Inc. Transaction History

Horizon Kinetics Asset Management LLC

  • $6.03 Billion
  • Q3 2024

A detailed history of Horizon Kinetics Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 25,845 shares of ABBV stock, worth $4.65 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
25,845
Previous 24,123 7.14%
Holding current value
$4.65 Million
Previous $4.14 Million 23.35%
% of portfolio
0.08%
Previous 0.08%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$163.84 - $199.33 $282,132 - $343,246
1,722 Added 7.14%
25,845 $5.1 Million
Q2 2024

Aug 14, 2024
BUY
$154.79 - $180.76 $16,407 - $19,160
106 Added 0.44%
24,123 $4.14 Million
Q1 2024

May 14, 2024
SELL
$159.82 - $182.1 $3,675 - $4,188
-23 Reduced 0.1%
24,017 $4.37 Million
Q4 2023

Feb 15, 2024
SELL
$137.6 - $154.97 $107,878 - $121,496
-784 Reduced 3.16%
24,040 $3.73 Million
Q3 2023

Nov 14, 2023
SELL
$133.59 - $154.65 $3,339 - $3,866
-25 Reduced 0.1%
24,824 $3.7 Million
Q2 2023

Aug 14, 2023
SELL
$132.51 - $164.9 $33,657 - $41,884
-254 Reduced 1.01%
24,849 $3.35 Million
Q1 2023

May 12, 2023
SELL
$144.61 - $166.54 $315,828 - $363,723
-2,184 Reduced 8.0%
25,103 $4 Million
Q3 2022

Nov 14, 2022
BUY
$134.21 - $153.93 $35,431 - $40,637
264 Added 0.98%
27,287 $3.66 Million
Q2 2022

Aug 05, 2022
SELL
$137.62 - $174.96 $185,098 - $235,321
-1,345 Reduced 4.74%
27,023 $4.14 Million
Q1 2022

May 13, 2022
SELL
$131.98 - $163.75 $26,395 - $32,750
-200 Reduced 0.7%
28,368 $4.6 Million
Q3 2021

Nov 15, 2021
SELL
$106.4 - $120.78 $53,200 - $60,390
-500 Reduced 1.72%
28,568 $3.08 Million
Q2 2021

Aug 16, 2021
BUY
$105.21 - $117.21 $6,417 - $7,149
61 Added 0.21%
29,068 $3.27 Million
Q1 2021

May 11, 2021
SELL
$102.3 - $112.62 $125,419 - $138,072
-1,226 Reduced 4.06%
29,007 $3.14 Million
Q4 2020

Feb 16, 2021
SELL
$80.49 - $108.67 $212,413 - $286,780
-2,639 Reduced 8.03%
30,233 $3.24 Million
Q3 2020

Nov 16, 2020
BUY
$85.91 - $100.83 $65,377 - $76,731
761 Added 2.37%
32,872 $2.88 Million
Q2 2020

Aug 14, 2020
SELL
$73.37 - $98.18 $76,304 - $102,107
-1,040 Reduced 3.14%
32,111 $3.15 Million
Q1 2020

May 13, 2020
BUY
$64.5 - $97.79 $120,421 - $182,573
1,867 Added 5.97%
33,151 $2.53 Million
Q4 2019

Feb 14, 2020
BUY
$72.13 - $90.25 $13,848 - $17,328
192 Added 0.62%
31,284 $2.77 Million
Q3 2019

Nov 14, 2019
BUY
$62.98 - $75.72 $27,144 - $32,635
431 Added 1.41%
31,092 $2.35 Million
Q2 2019

Aug 14, 2019
BUY
$65.7 - $83.98 $33,375 - $42,661
508 Added 1.68%
30,661 $2.23 Million
Q1 2019

May 15, 2019
BUY
$77.14 - $90.79 $2.33 Million - $2.74 Million
30,153 New
30,153 $2.43 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Horizon Kinetics Asset Management LLC Portfolio

Follow Horizon Kinetics Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email